Literature DB >> 28373149

Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome.

Zheng Chen1, Gui-Quan Shen2, Alexander Lerner3, Bo Gao4.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiological syndrome characterized by a variable combination of headaches, seizures, altered mental status, visual impairment, focal neurological signs and symmetric vasogenic edema in bilateral posterior cerebral circulation territory. The pathogenesis of PRES is still controversial. Most of the clinical conditions associated with PRES involve a systemic toxicity response in the entire organism with activation of the cells of the immune system and cytokines. These PRES related conditions induce T cell activation, cytokine release, and subsequent leukocyte adhesion and activation, resulting in endothelial damage and fluid leakage. This potential mechanism of immune system activation and endothelial dysfunction may play a critical role in the pathogenesis of PRES. In this review, the role of immune system activation and endothelial dysfunction in the pathogenesis of PRES is discussed, with the aim to improve our understanding of this disorder.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immune system activation; Pathogenesis; Posterior reversible encephalopathy syndrome (PRES)

Mesh:

Substances:

Year:  2017        PMID: 28373149     DOI: 10.1016/j.brainresbull.2017.03.012

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  14 in total

1.  Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.

Authors:  J Merayo-Chalico; A Barrera-Vargas; G Juárez-Vega; J Alcocer-Varela; A Arauz; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2018-01-16       Impact factor: 4.330

2.  Posterior reversible encephalopathy syndrome secondary to acute post-streptococcal glomerulonephritis in a child: a case report from the Tibetan plateau.

Authors:  Yanhui Shi; Shuang Ren; Liang Shu; Qiang Li
Journal:  BMC Neurol       Date:  2022-06-18       Impact factor: 2.903

3.  Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center.

Authors:  Günseli Orhun; Serra Sencer; Erdem Tüzün; Nerses Bebek; Perihan Ergin Özcan; Mehmet Barburoğlu; Mehmet Güven Günver; Figen Esen
Journal:  Neurocrit Care       Date:  2022-02-08       Impact factor: 3.532

4.  Hypertension, seizures, and epilepsy: a review on pathophysiology and management.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Chiara Sueri; Vittoria Cianci; Michele Ascoli; Salvatore M Cavalli; Ettore Beghi; Vincenzo Belcastro; Amedeo Bianchi; Paolo Benna; Roberto Cantello; Domenico Consoli; Fabrizio A De Falco; Giancarlo Di Gennaro; Antonio Gambardella; Gian Luigi Gigli; Alfonso Iudice; Angelo Labate; Roberto Michelucci; Maurizio Paciaroni; Pasquale Palumbo; Alberto Primavera; Ferdinando Sartucci; Pasquale Striano; Flavio Villani; Emilio Russo; Giovambattista De Sarro; Umberto Aguglia
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

5.  Posterior Reversible Encephalopathy Syndrome and Septic Encephalopathy: Neuroimaging, Inflammation and Neurodegeneration Findings.

Authors:  Günseli Orhun
Journal:  Noro Psikiyatr Ars       Date:  2019-10-09       Impact factor: 1.339

6.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

7.  Posterior reversible encephalopathy syndrome as the first clinical manifestation of lupus nephritis.

Authors:  Frederico Carvalho de Medeiros; Bárbara Márcia Rocha Sousa; Dandara Noária Cruz Santos; Gisele Novais Matias Sion; Cibele Fontes Alves
Journal:  Acta Neurol Belg       Date:  2021-02-16       Impact factor: 2.396

8.  Posterior Reversible Encephalopathy Syndrome: Incidence and Clinical Characteristics in Children With Cancer.

Authors:  Katherine R Sommers; Jodi Skiles; Brian Leland; Courtney M Rowan
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

9.  A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.

Authors:  Yang Yang; Xiyun Chen; Huijuan Wu; Hua Peng; Wenjing Sun; Bin He; Zhengang Yuan
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952

10.  Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report.

Authors:  Fangfang Shi; Liwei Shen; Yonghui Shi; Lei Shi; Xiaoli Yang; Zhi Jin; Wenpeng Liu; Danhong Wu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.